Duhao Net helps individual entrepreneurs and enterprises find high-quality suppliers, reduce procurement costs, and make transactions easier.
Release time:2025-06-28 09:29:32 Source:DuHao
Contact Us Today
Tel : +82 033-644-3116
Email: net.fei@163.com
Address: No. 178, Linyu Road, High-tech Development Zone, Changsha, Hunan, China.
Argus Pharmaceuticals, Ltd. is a leading Sino-foreign joint venture high-tech enterprise specializing in the research, development, production, and commercialization of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and formulations. Established in December 2007 and headquartered in Changsha National High-tech Industrial Development Zone, Argus has grown into a globally competitive player in the pharmaceutical industry, with a strong presence in domestic and international markets, including North America and Europe.
Argus Pharmaceuticals boasts internationally advanced technologies in microbial fermentation, macromolecular protein expression, and specialized synthesis. The company operates a world-class R&D laboratory, driving multiple innovative projects, and maintains large-scale production facilities, including microbial fermentation workshops, API production lines, and a fully compliant drug packaging workshop. All operations strictly adhere to GMP standards, ensuring product quality, safety, and timely delivery.
Argus’s flagship products include:
Orlistat: A globally recognized OTC weight-loss drug.
Rabeprazole Sodium: An API for acid-related gastrointestinal disorders.
With an annual production capacity covering the full supply chain—from raw materials to finished formulations—Argus serves major markets in China, Europe, and the U.S. Its unique "Information + Production" model enables rapid market response, helping clients identify high-potential products and accelerate industrialization.
Argus upholds the quality philosophy:
"The best work quality guarantees the best product quality, and the best product quality serves public health."
Quality Assurance (QA): A robust QA system oversees every production stage, from raw material procurement to final product release, ensuring compliance with GMP and regulatory requirements.
Quality Control (QC): Equipped with cutting-edge analytical instruments (e.g., HPLC, GC, UV spectrophotometers), the QC team rigorously tests raw materials, intermediates, and finished products to guarantee data accuracy and product efficacy.
Led by a Harvard postdoctoral expert, Argus’s R&D team collaborates with global research institutions, focusing on bio-fermentation and generic drug development. Notably, its Orlistat project passed China’s priority review in 2022, demonstrating rapid technology-to-market capabilities. The company holds 30 patents and is certified as a high-tech enterprise and "Specialized and Innovative" (Little Giant) firm.
2007: Founded as a wholly foreign-owned enterprise in Changsha.
2008: Launched Orlistat API production; obtained Drug Production License.
2009: Achieved international quality recognition; transitioned to a Sino-foreign joint venture.
2012: Secured Orlistat new drug approval; recognized as Changsha Enterprise Technology Center.
2016: Earned GMP certification.
Argus Pharmaceuticals is committed to enhancing global health by delivering high-quality, cost-effective generic drugs. Leveraging its technical expertise, agile production, and worldwide sales network, Argus empowers partners to bring innovative therapies to market efficiently, ensuring accessibility across every corner of the world.
Join us in turning pharmaceutical visions into reality!